pharmaceutical

Expediting Drug Development of Novel Therapeutics: Regulatory and Commercialization Implications of Digital Twin Technology in Clinical Trials

Jan. 24, 2024—By Colleen Carroll Clinical trials are a major bottleneck for new drug development.[1] No drug will make it to market without first meeting rigorous safety and efficacy standards. This requires extensive testing across multiple phases of clinical trials, which take, on average, ten and a half years.[2] But advances in AI may transform clinical trials...

Why Punish Pharma for Making Medicine? Preserving Patent Protections and Cutting Consumer Costs

Jun. 28, 2023—Alex Wharton | 25 Vand. J. Ent. & Tech. L. 603 (2023). The push to lower pharmaceutical drug prices has taken a stronger foothold in legislative and executive actions in recent years. With average prices rising continuously over the past decade, many consumers struggle to pay for the medications they need—insulin being the most often...